European Leukemia Trial Registry
Trial: ENEST1st

More Details
Title Nilotinib in adult patients with newly diagnosed Ph/BCR-ABL positive CML in chronic phase
Scientific Title A Phase IIIb, multicentre, open-label study of nilotinib in adult patients with newly diagnosed Philadlphia chromosome and/or BCR-ABL positive leukaemia (CML) in chronic phase (CP)
Short Title ENEST1st
Trialgroup NN
Type of Trial multicentric
Disease Chronic myeloid leukemia(CML) Chronic Phase
Age >= 18 years
Status No longer recruiting
Start of Recruitment 01.06.2011
Leader Le Coutre, Dr. med., Phillipp
Shortprotocol Shortprotocol
Remark Description: For each intervention, describe other intervention details as applicable (e.g., dose, duration, mode of administration, etc.).
created 17.05.2011 Johannes Kraus
changed 01.06.2015 Hanna Ebert
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org